Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.Hamaluba M, Sang S, Orindi B, Njau I, Karanja H, Kamau N, Gitonga JN, Mugo D, Wright D, Nyagwange J, Kutima B, Omuoyo D, Mwatasa M, Ngetsa C, Agoti C, Cheruiyot S, Nyaguara A, Munene M, Mturi N, Oloo E, Ochola-Oyier L, Mumba N, Mauncho C, Namayi R, Davies A, Tsofa B, Nduati EW, Aliyan N, Kasera K, Etyang A, Boyd A, Hill A, Gilbert S, Douglas A, Pollard A, Bejon P, Lambe T, Warimwe G
Wellcome Open Res, (2023). 8:182

A rapid review of community engagement and informed consent processes for adaptive platform trials and alternative design trials for public health emergencies.Davies A, Ormel I, Bernier A, Harriss E, Mumba N, Gobat N, Schwartz L, Cheah PY
Wellcome Open Res, (2023). 8:194

A network of empirical ethics teams embedded in research programmes across multiple sites: opportunities and challenges in contributing to COVID-19 research and responses.Ngwenya N, Ilo Van Nuil J, Nyirenda D, Chambers M, Cheah PY, Seeley J, Chi P, Mafuleka L, Nkosi B, Kamuya D, Davies A, Schneiders ML, Mumba N, Dlamini S, Desmond N, Marsh V, Rippon D, Parker M, Molyneux S
Wellcome Open Res, (2022). 7:48

Always leave the audience wanting more: An entertaining approach to stimulate engagement with health research among publics in coastal Kenya through 'Magnet Theatre'.Sanga G, Jao I, Mumba N, Mwalukore S, Kamuya D, Davies A
Wellcome Open Res, (2021). 6:2

Evolution of a programme to engage school students with health research and science in Kenya.Davies A, Mwangome N, Yeri B, Mwango G, Mumba N, Marsh V, Kamuya D, Molyneux S, Kinyanjui S, Jones C
Wellcome Open Res, (2019). 4:39